(Q35945454)

11 August 2017

1 reference

title

Frequency of new-onset diabetes mellitus and use of antipsychotic drugs among Central Texas veterans (English)

1 reference

11 August 2017

0 references

Jamie C Barner

1

1 reference

11 August 2017

Jason Worchel

series ordinal

2

1 reference

11 August 2017

Min Yang

series ordinal

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

24

1 reference

11 August 2017

issue

11

1 reference

11 August 2017

page(s)

1529-1538

1 reference

Bodyweight gain with atypical antipsychotics. A comparative review

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.16.1529.50952

Weight gain from novel antipsychotic drugs: need for action

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.16.1529.50952

Diabetic ketoacidosis and clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.16.1529.50952

Risperidone-associated new-onset diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.16.1529.50952

Olanzapine-induced glucose dysregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.16.1529.50952

Olanzapine-lnduced hyperglycemic nonketonic coma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.16.1529.50952

Olanzapine-induced diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.16.1529.50952

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.16.1529.50952

Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.16.1529.50952

Antipsychotic-induced type 2 diabetes: evidence from a large health plan database

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.16.1529.50952

Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.16.1529.50952

Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.16.1529.50952

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.16.1529.50952

Clozapine use and risk of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.16.1529.50952

Characteristics of suicide attempts in a large urban jail system with an established suicide prevention program

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.16.1529.50952

Incident Diabetes Associated With Antipsychotic Use in the United Kingdom General Practice Research Debate

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.16.1529.50952

10.1592/PHCO.24.16.1529.50952

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference